Hyperfine (HYPR) Beginning Cash Balance (2021)

Hyperfine (HYPR) reported Beginning Cash Balance of -$58374.0 for Q3 2021, down 182.06% quarter-over-quarter from $71134.0 in Q1 2021.

Hyperfine (HYPR) Beginning Cash Balance (2021) Analysis & Trends

Hyperfine has reported Beginning Cash Balance for 1 years, with the latest figure at -$58374.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn
10	Hyperfine	155.82 Mn	114.55 Mn	1.98 Mn

Download Data